CHEMICAL COMPOUNDS
    7.
    发明申请
    CHEMICAL COMPOUNDS 失效
    化学化合物

    公开(公告)号:US20080114049A1

    公开(公告)日:2008-05-15

    申请号:US11851459

    申请日:2007-09-07

    申请人: Romano Di Fabio

    发明人: Romano Di Fabio

    IPC分类号: A61K31/403 C07D209/02

    CPC分类号: C07D221/04

    摘要: The present invention relates to (1S,6R)-6-(3,4-dichlorophenyl)-1-[(methyloxy)methyl]-3-azabicyclo[4.1.0]heptane, pharmaceutically acceptable salts, prodrugs or solvates thereof; processes for their preparation, intermediates used in these processes, pharmaceutical compositions containing them and their use in therapy, as serotonin (5-HT), dopamine (DA) and norepinephrine (NE), re-uptake inhibitors.

    摘要翻译: 本发明涉及(1S,6R)-6-(3,4-二氯苯基)-1 - [(甲氧基)甲基] -3-氮杂双环[4.1.0]庚烷,其药学上可接受的盐,前药或溶剂合物; 再摄入抑制剂,作为5-羟色胺(5-HT),多巴胺(DA)和去甲肾上腺素(NE),再摄取抑制剂,它们的制备方法,这些方法中使用的中间体,含有它们的药物组合物及其在治疗中的应用。

    CRF receptor antagonists
    8.
    发明授权
    CRF receptor antagonists 失效
    CRF受体拮抗剂

    公开(公告)号:US07329667B2

    公开(公告)日:2008-02-12

    申请号:US10476441

    申请日:2002-04-30

    IPC分类号: A01N43/54 C07D239/00

    CPC分类号: C07D471/06 C07D487/06

    摘要: The present invention relates to tricyclic pyrimidines compounds of formula (I) including stereoisomers, prodrugs and pharmaceutically acceptable salts or solvates thereof, to processes for their preparation, to pharmaceutical compositions containing them and to their use in the treatment of conditions mediated by corticotropin-releasing factor (CRF).

    摘要翻译: 本发明涉及式(I)的三环嘧啶化合物,其包括立体异构体,其前药和药学上可接受的盐或溶剂化物,其制备方法,含有它们的药物组合物及其用于治疗由促肾上腺皮质激素释放介导的病症 因子(CRF)。